- <![CDATA[Disease Assessment and Mutational Testing in Progressive CLL]]><![CDATA[Experts discuss relapsed CLL workup, using PET-CT and lymph node biopsy to rule out Richter’s, plus resistance testing to guide next therapy.]]>onclive · 2mo ago↗ source
- <![CDATA[Clinical Scenario Presentation and Treatment Approach for Progressive Disease]]><![CDATA[Experts weigh mutation testing, comorbidities, and patient preference to guide second-line CLL options after BTK inhibitor resistance.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Pant on the Mechanism of Action of Daraxonrasib in PDAC]]><![CDATA[Shubham Pant, MD, MBBS, explains the unique "on-state" binding mechanism of daraxonrasib.]]>onclive · 2mo ago↗ source